Abdul Hamid Alraiyes, MD
Pulmonary Disease · Park Ridge, ILNPI 1861626731
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (59.7%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 84.9% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2023 at $25,145 and has fallen 72.0% since, to $7,040 in 2025. Among pulmonary disease clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 186 payments — averaging $409.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$65K
- Covidien LP$5K
- Pulmonx Corporation$3K
- Medtronic$790
- AstraZeneca$751
- Noah Medical Corporation$571
- plus $2K from 17 others
What the payments were for
- Consulting fees$4,1615%
- Speaking & faculty fees$8,62011%
- Travel & lodging$11,47815%
- Food & beverage$6,4448%
- Education$45,45060%
- Gifts$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 125 | $64,679 |
| Covidien LP | 13 | $4,853 |
| Pulmonx Corporation | 4 | $2,877 |
| Medtronic | 2 | $790 |
| AstraZeneca | 11 | $751 |
| Noah Medical Corporation | 5 | $571 |
| Johnson & Johnson | 3 | $517 |
| Pinnacle Biologics, Inc | 2 | $287 |
| Boston Scientific | 2 | $221 |
| Amgen | 5 | $129 |
| Siemens Medical Solutions USA, Inc. | 1 | $120 |
| Olympus America Inc. | 1 | $81 |
| Cook Medical LLC | 1 | $60 |
| Regeneron Healthcare Solutions, Inc. | 2 | $50 |
| Olympus Corporation Of The Americas | 1 | $26 |
| Taiho Oncology, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $21 |
| Coherus Oncology, Inc. | 1 | $20 |
| Merck | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Cumberland Pharmaceuticals, Inc. | 1 | $18 |
| Pfizer | 1 | $17 |
| Novartis | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$59,955
- superDimension$4,760
- DA VINCI SP$3,000
- ZEPHYR ENDOBRONCHIAL VALVE$2,877
- CHARTIS CATHETER$627
- ZEPHYR DELIVERY CATHETER$627
- PULMONX CHARTIS TABLET CONSOLE$627
- IMFINZI$552
- MONARCH$488
- Photofrin$200
- ACQUIRE$144
- Cios Spin$120
How this compares
$76,166 in reported general payments places this provider in the 95th percentile of 539 pulmonary disease providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Park Ridge
- Douglas HogarthChicago$2.9M
- Steven WhiteChicago$970K
- Momen WahidiChicago$779K
- Septimiu MurguChicago$633K
- Ayodeji AdegunsoyeChicago$561K
- Kristopher McDonoughJoliet$461K
- Ravi KalhanChicago$375K
- Brian GaribaldiChicago$356K
- Danish ThameemChampaign$353K
- Bradford BemissMaywood$259K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.